Arcturus Therapeutics: Q2 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Monday reported a loss of $17.2 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 64 cents.

The pharmaceutical company posted revenue of $49.9 million in the period.

Arcturus Therapeutics shares have fallen 37% since the beginning of the year. In the final minutes of trading on Monday, shares hit $19.80, a fall of 40% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT